2 completed, 1 unknown. 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Iodides: new trials by email Literature Review of Iodides trials Research Report on Iodides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of the Daily Average Requirement of Iodine in Lactating Women Control, Iodide (150 μg/day), Iodine (300 μg/day) - Healthy, Iodine Deficiency | Not applicable | Completed | University Children's Hospital, Zurich | 17 | 2022-05-06 | 2025-09-03 |
| Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain IoGen (molecular iodine) - Fibrocystic Disease of Breast, Fibrocystic Changes of Breast | Phase 3 | Unknown | Symbollon Pharmaceuticals | 175 | 2005-07-01 | 2007-06-18 |
| LISA-study : Levothyroxin in Nodular Goiter Levothyroxin-Na, Levothyroxine-Na + iodide, Iodide - Goiter, Nodular | Phase 4 | Completed | Sanofi | 1024 | 2004-05-01 | 2009-12-04 |
Cysts (1) · Fibrocystic Breast Disease (1) · Fibrosis (1) · Goiter, Nodular (1) · Mastodynia (1) · Pain (1)
Sanofi (1) · Symbollon Pharmaceuticals (1) · University Children's Hospital, Zurich (1)
Germany (1) · Switzerland (1) · United States (1)
Christian Braegger, M.D. (1) · Julia Kazakhin, M.D. (1) · Katrin Roscher (1)